GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » Gross Margin %

MedMen Enterprises (MedMen Enterprises) Gross Margin % : 48.29% (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. MedMen Enterprises's Gross Profit for the three months ended in Mar. 2023 was $13.1 Mil. MedMen Enterprises's Revenue for the three months ended in Mar. 2023 was $27.2 Mil. Therefore, MedMen Enterprises's Gross Margin % for the quarter that ended in Mar. 2023 was 48.29%.


The historical rank and industry rank for MedMen Enterprises's Gross Margin % or its related term are showing as below:


MMNFQ's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 47
* Ranked among companies with meaningful Gross Margin % only.

MedMen Enterprises had a gross margin of 48.29% for the quarter that ended in Mar. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for MedMen Enterprises was 0.00% per year.


MedMen Enterprises Gross Margin % Historical Data

The historical data trend for MedMen Enterprises's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises Gross Margin % Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.81 46.24 35.64 45.92 49.52

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.82 51.80 49.45 50.93 48.29

Competitive Comparison of MedMen Enterprises's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Gross Margin % distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Gross Margin % falls into.



MedMen Enterprises Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

MedMen Enterprises's Gross Margin for the fiscal year that ended in Jun. 2022 is calculated as

Gross Margin % (A: Jun. 2022 )=Gross Profit (A: Jun. 2022 ) / Revenue (A: Jun. 2022 )
=69.7 / 140.812
=(Revenue - Cost of Goods Sold) / Revenue
=(140.812 - 71.085) / 140.812
=49.52 %

MedMen Enterprises's Gross Margin for the quarter that ended in Mar. 2023 is calculated as


Gross Margin % (Q: Mar. 2023 )=Gross Profit (Q: Mar. 2023 ) / Revenue (Q: Mar. 2023 )
=13.1 / 27.225
=(Revenue - Cost of Goods Sold) / Revenue
=(27.225 - 14.077) / 27.225
=48.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


MedMen Enterprises  (OTCPK:MMNFQ) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

MedMen Enterprises had a gross margin of 48.29% for the quarter that ended in Mar. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


MedMen Enterprises Gross Margin % Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

MedMen Enterprises (MedMen Enterprises) Headlines